vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and PCB BANCORP (PCB). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $19.2M, roughly 1.5× Apyx Medical Corp). On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 11.3%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 10.4%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
APYX vs PCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $29.2M |
| Net Profit | $-1.3M | — |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 45.0% |
| Net Margin | -6.8% | — |
| Revenue YoY | 34.7% | 11.3% |
| Net Profit YoY | 71.9% | — |
| EPS (diluted) | — | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $29.2M | ||
| Q3 25 | $12.9M | $30.4M | ||
| Q2 25 | $11.4M | $29.3M | ||
| Q1 25 | $9.4M | $26.9M | ||
| Q4 24 | $14.2M | $26.2M | ||
| Q3 24 | $11.5M | $25.3M | ||
| Q2 24 | $12.1M | $24.2M | ||
| Q1 24 | $10.2M | $23.9M |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-2.0M | $11.4M | ||
| Q2 25 | $-3.8M | $9.1M | ||
| Q1 25 | $-4.2M | $7.7M | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-4.7M | $7.8M | ||
| Q2 24 | $-6.6M | $6.3M | ||
| Q1 24 | $-7.6M | $4.7M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 45.0% | ||
| Q3 25 | -6.5% | 52.3% | ||
| Q2 25 | -22.6% | 43.3% | ||
| Q1 25 | -32.4% | 40.2% | ||
| Q4 24 | -21.4% | 39.3% | ||
| Q3 24 | -31.6% | 42.2% | ||
| Q2 24 | -45.7% | 36.3% | ||
| Q1 24 | -64.6% | 27.2% |
| Q4 25 | -6.8% | — | ||
| Q3 25 | -15.4% | 37.5% | ||
| Q2 25 | -33.2% | 31.0% | ||
| Q1 25 | -44.0% | 28.8% | ||
| Q4 24 | -32.5% | — | ||
| Q3 24 | -40.9% | 30.8% | ||
| Q2 24 | -54.0% | 25.9% | ||
| Q1 24 | -74.0% | 19.6% |
| Q4 25 | — | $0.65 | ||
| Q3 25 | — | $0.78 | ||
| Q2 25 | — | $0.62 | ||
| Q1 25 | — | $0.53 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $0.52 | ||
| Q2 24 | $-0.19 | $0.43 | ||
| Q1 24 | $-0.22 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $207.1M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $390.0M |
| Total Assets | $66.8M | $3.3B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $207.1M | ||
| Q3 25 | $25.1M | $369.5M | ||
| Q2 25 | $29.3M | $263.6M | ||
| Q1 25 | $31.0M | $214.3M | ||
| Q4 24 | $31.7M | $198.8M | ||
| Q3 24 | $28.0M | $193.1M | ||
| Q2 24 | $32.7M | $177.6M | ||
| Q1 24 | $37.3M | $239.8M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $390.0M | ||
| Q3 25 | $5.8M | $384.5M | ||
| Q2 25 | $7.3M | $376.5M | ||
| Q1 25 | $10.5M | $370.9M | ||
| Q4 24 | $14.2M | $363.8M | ||
| Q3 24 | $11.0M | $362.3M | ||
| Q2 24 | $14.7M | $353.5M | ||
| Q1 24 | $20.3M | $350.0M |
| Q4 25 | $66.8M | $3.3B | ||
| Q3 25 | $57.4M | $3.4B | ||
| Q2 25 | $58.2M | $3.3B | ||
| Q1 25 | $60.2M | $3.2B | ||
| Q4 24 | $64.8M | $3.1B | ||
| Q3 24 | $60.7M | $2.9B | ||
| Q2 24 | $65.4M | $2.9B | ||
| Q1 24 | $70.7M | $2.9B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $26.6M |
| Free Cash FlowOCF − Capex | $-2.8M | $24.4M |
| FCF MarginFCF / Revenue | -14.6% | 83.6% |
| Capex IntensityCapex / Revenue | 1.4% | 7.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $26.6M | ||
| Q3 25 | $-3.5M | $16.4M | ||
| Q2 25 | $-1.2M | $4.9M | ||
| Q1 25 | $-702.0K | $2.3M | ||
| Q4 24 | $-2.9M | $39.0M | ||
| Q3 24 | $-4.4M | $11.9M | ||
| Q2 24 | $-4.3M | $14.6M | ||
| Q1 24 | $-6.3M | $8.2M |
| Q4 25 | $-2.8M | $24.4M | ||
| Q3 25 | $-4.1M | $16.2M | ||
| Q2 25 | $-1.5M | $3.8M | ||
| Q1 25 | $-757.0K | $1.6M | ||
| Q4 24 | $-3.2M | $34.9M | ||
| Q3 24 | $-4.6M | $11.9M | ||
| Q2 24 | $-4.6M | $12.8M | ||
| Q1 24 | $-6.4M | $6.0M |
| Q4 25 | -14.6% | 83.6% | ||
| Q3 25 | -31.5% | 53.2% | ||
| Q2 25 | -13.2% | 13.1% | ||
| Q1 25 | -8.0% | 6.0% | ||
| Q4 24 | -22.4% | 133.2% | ||
| Q3 24 | -40.0% | 46.8% | ||
| Q2 24 | -38.0% | 53.1% | ||
| Q1 24 | -62.2% | 25.2% |
| Q4 25 | 1.4% | 7.5% | ||
| Q3 25 | 4.0% | 0.8% | ||
| Q2 25 | 2.3% | 3.7% | ||
| Q1 25 | 0.6% | 2.8% | ||
| Q4 24 | 1.7% | 15.5% | ||
| Q3 24 | 1.3% | 0.1% | ||
| Q2 24 | 2.4% | 7.3% | ||
| Q1 24 | 0.3% | 9.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.33× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
